First Time Loading...

Enlivex Therapeutics Ltd
NASDAQ:ENLV

Watchlist Manager
Enlivex Therapeutics Ltd Logo
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Watchlist
Price: 1.62 USD Market Closed
Updated: May 6, 2024

Enlivex Therapeutics Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enlivex Therapeutics Ltd
Cash from Financing Activities Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Cash from Financing Activities
$360k
CAGR 3-Years
-78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cash from Financing Activities
$1.1m
CAGR 3-Years
-37%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cash from Financing Activities
$22.7m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Urogen Pharma Ltd
NASDAQ:URGN
Cash from Financing Activities
$116.9m
CAGR 3-Years
92%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cash from Financing Activities
$6m
CAGR 3-Years
14%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cash from Financing Activities
-₪1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Enlivex Therapeutics Ltd's Cash from Financing Activities?
Cash from Financing Activities
360k USD

Based on the financial report for Dec 31, 2023, Enlivex Therapeutics Ltd's Cash from Financing Activities amounts to 360k USD.

What is Enlivex Therapeutics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-78%

Over the last year, the Cash from Financing Activities growth was 140%. The average annual Cash from Financing Activities growth rates for Enlivex Therapeutics Ltd have been -78% over the past three years .